BNGO

Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Nov 10, 7:23 PMBionano Q3 2026 loss $0.54 vs $0.45 est, reiterates going-concern warning as cash and securities fall to $8.7m

Peers: PACB TXG HBIO ILMN LAB A QSI QTRX SEER NAUT

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	15.58M
Enterprise Value	13.45M
Income	-30.11M
Sales	31.09M
Book/sh	2.09
Cash/sh	0.62
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	97
IPO	Sep 21, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	0.50
P/B	0.53
P/C	1.80
P/FCF	-
EV/EBITDA	-
EV/Sales	0.43
Quick Ratio	1.54
Current Ratio	2.07
Debt/Eq	0.23
LT Debt/Eq	0.20
Option/Short	No / Yes

EPS (ttm)	-2.68
EPS next Y	-0.97
EPS next Q	-0.39
EPS this Y	67.10%
EPS next Y	54.67%
EPS next 5Y	56.92%
EPS past 3/5Y	73.98% 54.05%
Sales past 3/5Y	0.84% 27.37%
EPS Y/Y TTM	91.68%
Sales Y/Y TTM	8.23%
EPS Q/Q	66.21%
Sales Q/Q	12.34%
Earnings	Nov 10 AMC
EPS/Sales Surpr.	0.00% -1.98%

Insider Own	5.93%
Insider Trans	0.97%
Inst Own	17.74%
Inst Trans	-1.09%
ROA	-48.04%
ROE	-77.20%
ROIC	-88.85%
Gross Margin	47.98%
Oper. Margin	-97.11%
Profit Margin	-96.87%
SMA20	-6.64%
SMA50	-18.39%
SMA200	-9.12%
Trades

Shs Outstand	13.51M
Shs Float	13.15M
Short Float	10.55%
Short Ratio	1.47
Short Interest	1.39M
52W High	2.23 -50.00%
52W Low	1.00 11.50%
Volatility	8.41% 6.46%
ATR (14)	0.10
RSI (14)	39.27
Beta	1.68
Rel Volume	0.76
Avg Volume	940.96K
Volume	456,565

Perf Week	-6.30%
Perf Month	-18.01%
Perf Quarter	-5.51%
Perf Half Y	-10.80%
Perf YTD	-27.12%
Perf Year	-31.17%
Perf 3Y	-98.57%
Perf 5Y	-99.96%
Perf 10Y	-
Recom	1.00
Target Price	4.00
Prev Close	1.23
Price	1.12
Change %	-9.35%

Consensus

Strong Buy

Avg. Price Target

$4.00

Implied Upside

+258.7%

Analysts4incl. previous ratings

Rating Distribution2 Buy · 2 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Nov 15, 2024	Downgrade	LLadenburg Thalmann	Buy → Neutral
Sep 10, 2024	Downgrade	BBTIG Research	Buy → Neutral
Jan 05, 2023	Initiated	BScotiabank	Sector Outperform	$4	+258.7%
Dec 12, 2022	Resumed	BBTIG Research	Buy	$3.50	+213.9%
Jul 18, 2022	Resumed	OOppenheimer	Outperform	$12	+976.2%
Jun 16, 2021	Initiated	BBTIG Research	Buy	$10	+796.9%
Sep 24, 2020	Initiated	LLadenburg Thalmann	Buy	$1.25	+12.1%
Apr 08, 2020	Initiated	OOppenheimer	Outperform	$1.50	+34.5%

Nov-10-26 05:47PM	Bionano Misses As Growth Slows And Cash Thins, Leaving A Reimbursement-Driven 2027 Story To Carry The Weight (Earnings Whispers) +6.03% -9.35%
04:05PM	Bionano Reports Third Quarter 2026 Results and Provides a Business Update (GlobeNewswire)
Nov-03-26 09:10AM	Bionano's Q3 Test: Can Flow Cell Supply And Thin Cash Keep Pace With Demand? (Earnings Whispers)
Oct-27-26 04:05PM	Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026 (GlobeNewswire) +5.17%
Sep-14-26 09:00AM	Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia (GlobeNewswire) +9.02%
08:00AM	Loading…
Aug-24-26 08:00AM	Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference (GlobeNewswire)
Aug-11-26 01:03AM	Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... (GuruFocus.com)
Aug-10-26 04:05PM	Bionano Reports Second Quarter 2026 Results and Provides a Business Update (GlobeNewswire)
Aug-07-26 09:25AM	Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Value Sees 27% Upside (GuruFocus.com) +5.45%
Jul-27-26 04:05PM	Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 (GlobeNewswire)
Jun-24-26 08:30AM	Bionano Announces Hiring of Chief Scientific Officer (GlobeNewswire)
Jun-18-26 08:00AM	Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption (GlobeNewswire)
Jun-11-26 08:00AM	Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders (GlobeNewswire)
May-28-26 08:00AM	Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures (GlobeNewswire)
May-26-26 08:00AM	Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia (GlobeNewswire)
04:51PM	Loading…
May-20-26 04:51PM	Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder (IPO-Edge.com) +5.98%
May-14-26 01:02AM	Bionano Genomics Inc (BNGO) Q1 2026 Earnings Call Highlights: Record Flow Cell Sales and ... (GuruFocus.com)
May-13-26 04:05PM	Bionano Reports First Quarter 2026 Results and Provides a Business Update (GlobeNewswire)
May-12-26 09:23AM	Bionano Genomics Inc (BNGO) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
May-06-26 04:30PM	Bionano Announces Leadership Transition (GlobeNewswire)
May-05-26 08:00AM	Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 (GlobeNewswire)
Apr-29-26 04:05PM	Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 (GlobeNewswire)
Apr-02-26 08:00AM	Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma (GlobeNewswire)
Mar-23-26 11:00PM	Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) +26.96% -19.18%
04:05PM	Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 (GlobeNewswire)
Mar-17-26 08:00AM	Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting (GlobeNewswire)
Mar-09-26 04:05PM	Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 (GlobeNewswire)
Feb-27-26 08:00AM	Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale (GlobeNewswire)
Feb-26-26 08:00AM	10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders (GlobeNewswire)
Feb-25-26 08:00AM	11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy (GlobeNewswire)
08:00AM	Loading…
Feb-24-26 08:00AM	9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies (GlobeNewswire)
Feb-09-26 09:05AM	Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping (GlobeNewswire)
Feb-04-26 08:00AM	Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies (GlobeNewswire)
Jan-23-26 09:40AM	Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-12-26 08:00AM	Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results (GlobeNewswire)
Dec-11-25 08:00AM	Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 (GlobeNewswire)
Dec-03-25 08:00AM	Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies (GlobeNewswire)
Nov-14-25 12:03AM	Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... (GuruFocus.com)
Nov-13-25 04:01PM	Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress (GlobeNewswire) -8.12%
Nov-12-25 05:15PM	iBio, Inc. (IBIO) Reports Q1 Loss (Zacks)
07:39AM	Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result (GuruFocus.com)
Nov-06-25 08:00AM	Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia (GlobeNewswire)
Nov-05-25 05:40PM	Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 05:55PM	Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates (Zacks)
Oct-30-25 04:05PM	Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025 (GlobeNewswire)
Oct-23-25 08:00AM	Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting (GlobeNewswire)
Oct-07-25 08:00AM	Bionano to Participate in the H.C. Wainwright @ Home Event (GlobeNewswire)
Sep-21-25 09:11AM	Bionano Genomics Launches $10 Million Public Offering (Insider Monkey)
Sep-17-25 05:00PM	Bionano Genomics, Inc. Announces Closing of $10 Million Public O?ering (GlobeNewswire)
Sep-16-25 09:10AM	Bionano Genomics, Inc. Announces Pricing of $10 Million Public O?ering (GlobeNewswire) -35.74%
07:00AM	Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology (GlobeNewswire)
Sep-15-25 07:00AM	CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders (GlobeNewswire) -28.61%
Sep-08-25 04:30PM	Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock (Zacks) +6.77%
Aug-25-25 08:00AM	Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-22-25 08:50AM	Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Aug-15-25 03:23AM	Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com) -5.30%
Aug-14-25 04:01PM	Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress (GlobeNewswire)
Aug-07-25 08:00AM	Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL (GlobeNewswire)
Aug-06-25 08:00AM	Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Aug-05-25 08:00AM	Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate (GlobeNewswire)
Jul-31-25 04:05PM	Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025 (GlobeNewswire)
Jul-30-25 08:00AM	Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium (GlobeNewswire)
Jun-18-25 08:00AM	Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy (GlobeNewswire)
May-15-25 07:43AM	Q1 2025 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents) +5.08%
03:16AM	Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
May-14-25 04:01PM	Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress (GlobeNewswire) -5.32%
May-13-25 05:30PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-07-25 04:01PM	Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 (GlobeNewswire)
May-02-25 09:30AM	International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers (GlobeNewswire)
Apr-23-25 08:00AM	Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease (GlobeNewswire)
Apr-08-25 08:00AM	Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM (GlobeNewswire)
Apr-01-25 12:26PM	Q4 2024 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents) +11.11%
03:04AM	Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... (GuruFocus.com)
Mar-31-25 08:30PM	Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript (Motley Fool)
08:11PM	Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
04:01PM	Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 (GlobeNewswire)
Mar-24-25 08:00AM	Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect (GlobeNewswire)
Mar-18-25 08:00AM	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting (GlobeNewswire) -5.19%
Mar-14-25 08:00AM	Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 (GlobeNewswire)
Mar-13-25 09:00AM	Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML (GlobeNewswire) -8.03%
Jan-22-25 04:05PM	Bionano Announces Effective Date of Reverse Stock Split (GlobeNewswire) -28.68%
Jan-14-25 08:00AM	Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss (GlobeNewswire) -7.94%
Jan-13-25 08:00AM	Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results (GlobeNewswire)
Jan-07-25 08:00AM	Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia (GlobeNewswire)
07:30AM	BioNano Genomics Announces $10 Million Direct Offering (TipRanks)
Jan-06-25 04:30PM	Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) -11.68%
Jan-03-25 02:34PM	Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) +24.05%
Dec-31-24 03:26PM	Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway (GlobeNewswire)
Dec-23-24 08:30AM	Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis (GlobeNewswire)
Dec-19-24 08:00AM	Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal (GlobeNewswire)
Dec-10-24 08:00AM	Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell and Gene Therapy (GlobeNewswire) -5.96%
08:00AM	Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy (GlobeNewswire)
Nov-14-24 02:15AM	Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com) -7.58%
Nov-13-24 08:45PM	Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript (Motley Fool)
04:01PM	Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
Nov-07-24 04:01PM	Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 (GlobeNewswire) -5.26%
Oct-31-24 04:30PM	Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) -14.49%
08:10AM	Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 (GlobeNewswire)
08:00AM	Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire)
Oct-24-24 08:00AM	Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Luderer Albert	Interim Chief Executive	Sep 04 '26	Buy	1.21	4,000	4,845	8,000	Sep 09 04:30 PM
Luderer Albert	Interim Chief Executive	Aug 21 '26	Buy	1.22	4,000	4,860	4,000	Aug 21 04:30 PM

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

ChairmanDr. Albert A. Luderer Ph.D.

Chief Operating OfficerMr. Mark Oldakowski

Chief Accounting OfficerMr. Mark Adamchak C.P.A.

Chief Scientific OfficerDr. Alex Hastie Ph.D.

Chief Legal Officer & Corporate SecretaryMr. Jonathan Dixon J.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

Bionano Genomics Inc

Upgrade your Finviz experience

All the Features.
Half the Price.